Kameda Medical Center
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.kameda.com
The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine
Phase 4
Completed
- Conditions
- Pneumococcal PneumoniaInfluenza
- Interventions
- Biological: Sequential administration of Pneumovax NP® and Fluvic HA syringe®Biological: Simultaneous administration of Pneumovax NP® and Fluvic HA syringe®
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Kameda Medical Center
- Target Recruit Count
- 162
- Registration Number
- NCT02592486
- Locations
- 🇯🇵
Department of Pulmonary Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan
© Copyright 2025. All Rights Reserved by MedPath